Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia
H Kantarjian, C Sawyers, A Hochhaus… - … England Journal of …, 2002 - Mass Medical Soc
Background Chronic myelogenous leukemia (CML) is caused by the BCR-ABL tyrosine
kinase, the product of the Philadelphia chromosome. Imatinib mesylate, formerly STI571, is a …
kinase, the product of the Philadelphia chromosome. Imatinib mesylate, formerly STI571, is a …
Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia
H Kantarjian, C Sawyers, A Hochhaus… - … England Journal of …, 2002 - ohsu.elsevierpure.com
Background. Chronic myelogenous leukemia (CML) is caused by the BCR-ABL tyrosine
kinase, the product of the Philadelphia chromosome. Imatinib mesylate, formerly STI571, is a …
kinase, the product of the Philadelphia chromosome. Imatinib mesylate, formerly STI571, is a …
[引用][C] Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia
H KANTARJIAN - N Engl J Med, 2002 - cir.nii.ac.jp
[引用][C] Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia
H KANTARJIAN, C SAWYERS… - The New England …, 2002 - pascal-francis.inist.fr
Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous
leukemia CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
leukemia CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia
H Kantarjian, C Sawyers… - New England …, 2002 - mdanderson.elsevierpure.com
Background. Chronic myelogenous leukemia (CML) is caused by the BCR-ABL tyrosine
kinase, the product of the Philadelphia chromosome. Imatinib mesylate, formerly STI571, is a …
kinase, the product of the Philadelphia chromosome. Imatinib mesylate, formerly STI571, is a …
Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia
H Kantarjian, C Sawyers… - The New England …, 2002 - pubmed.ncbi.nlm.nih.gov
Background Chronic myelogenous leukemia (CML) is caused by the BCR-ABL tyrosine
kinase, the product of the Philadelphia chromosome. Imatinib mesylate, formerly STI571, is a …
kinase, the product of the Philadelphia chromosome. Imatinib mesylate, formerly STI571, is a …
[引用][C] Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia
H Kantarjian, C Sawyers, A Hochhaus… - NEW ENGLAND …, 2002 - iris.unito.it
KANTARJIAN H; SAWYERS C; HOCHHAUS A; GUILHOT F; SCHIFFER C; GAMBACORTI-
PASSERINI C; NIEDERWIESER D; RESTA D; CAPDEVILLE R; ZOELLNER U; TALPAZ M; …
PASSERINI C; NIEDERWIESER D; RESTA D; CAPDEVILLE R; ZOELLNER U; TALPAZ M; …
[PDF][PDF] HEMATOLOGIC AND CYTOGENETIC RESPONSES TO IMATINIB MESYLATE IN CHRONIC MYELOGENOUS LEUKEMIA
H KANTARJIAN, C SAWYERS, A HOCHHAUS… - N Engl J …, 2002 - researchgate.net
Background Chronic myelogenous leukemia (CML) is caused by the BCR-ABL tyrosine
kinase, the product of the Philadelphia chromosome. Imatinib mesylate, formerly STI571, is a …
kinase, the product of the Philadelphia chromosome. Imatinib mesylate, formerly STI571, is a …
Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia.
H Kantarjian, C Sawyers, A Hochhaus… - The New England …, 2002 - europepmc.org
Background Chronic myelogenous leukemia (CML) is caused by the BCR-ABL tyrosine
kinase, the product of the Philadelphia chromosome. Imatinib mesylate, formerly STI571, is a …
kinase, the product of the Philadelphia chromosome. Imatinib mesylate, formerly STI571, is a …
[引用][C] Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia
H KANTARJIAN - N. Engl. J. Med., 2002 - cir.nii.ac.jp